Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

Therapeutic phlebotomy is safe in children with sickle cell anaemia and can be effective treatment for transfusional iron overload.

Aygun B, Mortier NA, Kesler K, Lockhart A, Schultz WH, Cohen AR, Alvarez O, Rogers ZR, Kwiatkowski JL, Miller ST, Sylvestre P, Iyer R, Lane PA, Ware RE; Stroke With Transfusions Changing to Hydroxyurea (SWiTCH) Trial Investigators..

Br J Haematol. 2015 Apr;169(2):262-6. doi: 10.1111/bjh.13280. Epub 2015 Jan 22.

2.

Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial.

Helton KJ, Adams RJ, Kesler KL, Lockhart A, Aygun B, Driscoll C, Heeney MM, Jackson SM, Krishnamurti L, Miller ST, Sarnaik SA, Schultz WH, Ware RE; SWiTCH Investigators..

Blood. 2014 Aug 7;124(6):891-8. doi: 10.1182/blood-2013-12-545186. Epub 2014 Jun 9.

3.

Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: results from the SWiTCH clinical trial.

Alvarez O, Yovetich NA, Scott JP, Owen W, Miller ST, Schultz W, Lockhart A, Aygun B, Flanagan J, Bonner M, Mueller BU, Ware RE; Investigators of the Stroke With Transfusions Changing to Hydroxyurea Clinical Trial (SWiTCH)..

Am J Hematol. 2013 Nov;88(11):932-8. doi: 10.1002/ajh.23547. Epub 2013 Aug 30.

4.

Transcranial Doppler velocity and brain MRI/MRA changes in children with sickle cell anemia on chronic transfusions to prevent primary stroke.

Sheehan VA, Hansbury EN, Smeltzer MP, Fortner G, McCarville MB, Aygun B.

Pediatr Blood Cancer. 2013 Sep;60(9):1499-502. doi: 10.1002/pbc.24569. Epub 2013 Apr 26.

PMID:
23625812
5.

The impact of preparation and support procedures for children with sickle cell disease undergoing MRI.

Cejda KR, Smeltzer MP, Hansbury EN, McCarville ME, Helton KJ, Hankins JS.

Pediatr Radiol. 2012 Oct;42(10):1223-8. doi: 10.1007/s00247-012-2422-2. Epub 2012 Jun 19.

PMID:
22710740
6.

Bone marrow transplant options and preferences in a sickle cell anemia cohort on chronic transfusions.

Hansbury EN, Schultz WH, Ware RE, Aygun B.

Pediatr Blood Cancer. 2012 Apr;58(4):611-5.

PMID:
22435112
7.

Stroke With Transfusions Changing to Hydroxyurea (SWiTCH).

Ware RE, Helms RW; SWiTCH Investigators..

Blood. 2012 Apr 26;119(17):3925-32. doi: 10.1182/blood-2011-11-392340. Epub 2012 Feb 7.

8.

Chronic transfusion practices for prevention of primary stroke in children with sickle cell anemia and abnormal TCD velocities.

Aygun B, Wruck LM, Schultz WH, Mueller BU, Brown C, Luchtman-Jones L, Jackson S, Iyer R, Rogers ZR, Sarnaik S, Thompson AA, Gauger C, Helms RW, Ware RE; TCD With Transfusions Changing to Hydroxyurea (TWiTCH) Trial Investigators..

Am J Hematol. 2012 Apr;87(4):428-30. doi: 10.1002/ajh.23105. Epub 2012 Jan 9. No abstract available.

9.

Effects of chronic transfusions on abdominal sonographic abnormalities in children with sickle cell anemia.

McCarville MB, Rogers ZR, Sarnaik S, Scott P, Aygun B, Hilliard L, Lee MT, Kalinyak K, Owen W, Garro J, Schultz W, Yovetich N, Ware RE; SWiTCH Investigators..

J Pediatr. 2012 Feb;160(2):281-285.e1. doi: 10.1016/j.jpeds.2011.07.050. Epub 2011 Sep 9.

10.

Chronic transfusion practice for children with sickle cell anaemia and stroke.

Aygun B, McMurray MA, Schultz WH, Kwiatkowski JL, Hilliard L, Alvarez O, Heeney M, Kalinyak K, Lee MT, Miller S, Helms RW, Ware RE; SWiTCH Trial Investigators..

Br J Haematol. 2009 May;145(4):524-8. doi: 10.1111/j.1365-2141.2009.07630.x. Epub 2008 Mar 13.

PMID:
19344396
11.
12.

Purification and properties of sterol carrier protein2.

Noland BJ, Arebalo RE, Hansbury E, Scallen TJ.

J Biol Chem. 1980 May 10;255(9):4282-9. No abstract available.

13.
15.

Purification and properties of sterol carrier protein1.

Srikantaiah MV, Hansbury E, Loughran ED, Scallen TJ.

J Biol Chem. 1976 Sep 25;251(18):5496-504.

16.

Sterol carrier protein hypothesis: requirement for three substrate-specific soluble proteins in liver cholesterol biosynthesis.

Scallen TJ, Seetharam B, Srikantaiah MV, Hansbury E, Lewis MK.

Life Sci. 1975 Mar 15;16(6):853-73. Review. No abstract available.

PMID:
165341
17.

Proceedings: Sterol carrier protein hypothesis.

Scallen TJ, Srikantaiah MV, Seetharam B, Hansbury E, Gavey KL.

Fed Proc. 1974 Jun;33(6):1733-46. No abstract available.

PMID:
4827525
18.

Conversion of diglyceride to triglyceride by rat liver microsomes: a requirement for the 105,000 x g supernatant.

Manley ER, Skrdlant HB, Hansbury E, Scallen TJ.

Biochem Biophys Res Commun. 1974 May 7;58(1):229-35. No abstract available.

PMID:
4364617
19.

Characterization of native sterol carrier protein.

Scallen TJ, Srikantaiah MV, Skrdlant HB, Hansbury E.

FEBS Lett. 1972 Sep 15;25(2):227-233. No abstract available.

20.

Early stages in complementary synthesis directed by synthetic single stranded polydeosyribonucleotide templates and catalyzed by calf thymus deoxyribonucleic acid polymerase.

Hayes FN, Hansbury E, Mitchell VE, Ratliff RL, Smith DA, Williams DL.

J Biol Chem. 1971 Jun 10;246(11):3631-8. No abstract available.

Supplemental Content

Loading ...
Support Center